Select company
- Ticker/CompanyMarket Cap.
No results found
Select metric
Pick a metric...
6.64Price to Sales
VS
Market
Sector
Industry
History
$ 12.16Close
$ 5.86 - $ 16.56 52-Week Range
Ticker Information
Ticker
CRMDCompany Name
CORMEDIX INCSector
HealthcareIndustry
BiotechnologyExchange
NASDAQCORMEDIX INC - Price to Sales Chart Analysis (TTM)
From
Zoom
1Y
3Y
5Y
10Y
CRMD - P/S Historical data
| Date | Market Capitalization | Price to Sales | Revenues |
|---|---|---|---|
| 6/30/2025 | $ 806.96M | 6.64 | $ 121.48M |
| 3/31/2025 | $ 756.92M | 9.17 | $ 82.55M |
| 12/31/2024 | $ 478.43M | 11.01 | $ 43.47M |
| 9/30/2024 | $ 609.81M | 49.73 | $ 12.26M |
| 6/30/2024 | $ 274.83M | 340.93 | $ 806.12K |
| 3/31/2024 | $ 297.33M | 0 | $ 0 |
| 12/31/2023 | $ 188.04M | 0 | $ 0 |
| 9/30/2023 | $ 171.56M | 5.78K | $ 29.7K |
| 6/30/2023 | $ 242.24M | 6.63K | $ 36.52K |
| 3/31/2023 | $ 233.7M | 4.05K | $ 57.77K |
Key Performance Insights, Last 5 Years
- CORMEDIX INC's latest trailing twelve months (TTM) P/S stands at 829.94.
- Over the past 5 years, CORMEDIX INC's average P/S has been 1.66K.
- The median P/S for CORMEDIX INC during this period was 1.09K
- CORMEDIX INC reached its highest P/S over the past 5 years at 6.63K.
- The lowest P/S recorded by CORMEDIX INC in the same timeframe 6.64
CORMEDIX INC's P/S vs. competitors
We picked the following companies as peers based on multiple factors, including sector, industry, market capitalization and revenue
P/S Benchmarks
Similar metrics to Revenues:
- Price to Free Cash Flow - [Calculation] Measures a company’s [MarketCap] in relation to its Free Cash Flow [FCF].
- Price to Operating Cash Flow - [Calculation] Measures a company’s [MarketCap] in relation to its Operating Cash Flow [NCFO].
- Price to Book - [Calculation] Measures a company’s [MarketCap] in relation to its [Equity] which is the value of [Assets] minus [Liabilities].
- Enterprise Value over Free Cash Flow - [Calculation] Measures a company’s Enterprise Value [EV] in relation to its Free Cash Flow [FCF].
- Free Cash Flow Yield - [Calculation] The Free Cash Flow Yield, also known as the inverse of the Price to Free Cash Flow ratio [PFCF], expresses a company’s Free Cash Flow [FCF] as a percentage of [MarketCap.
Definition of Price to Sales
[Calculation] Measures a company’s [MarketCap] in relation to its [Revenue].Market Cap / Revenues
(=) P/S P/S for CORMEDIX INC is calculated as follows: Market Cap [ $ 172.87M ] / Revenues [ $ 208.29K ]
(=) P/S [ 829.94 ] CRMD - Price to Sales, Last 5 years
6.64
Minimum
Jun 30, 2025
6.63K
Maximum
Jun 30, 2023
1.66K
Average
1.09K
Median
P/S Benchmark AnalysisMarket
The chart above depicts the distribution of P/S for companies in the Total Stock Market. The average P/S of the companies is 2.62 with a standard deviation of 2.38.
The following table provides additional summary stats:
P/S in the Market:
| filtered constituents | 3.42K |
|---|---|
| min | 0 |
| max | 11.15 |
| average | 2.62 |
| median | 1.97 |
| std | 2.38 |